Get 40% Off
These stocks are up over 10% post earnings. Did you spot the buying opportunity? Our AI did.Read how

Generex in dispute with debt holder demanding immediate repayment

Published 02/04/2019, 02:18 PM
© Reuters.  Generex in dispute with debt holder demanding immediate repayment
  • Generex Biotechnology (OTCQB:GNBT +1.4%) has disclosed a dispute with Alpha Capital Anstalt, the holder of a note due October 26 valued at $682K, who is demanding immediate repayment triggered by an alleged default by not up-listing to Nasdaq within 90 days of the transaction.
  • The company counters that Alpha intentionally sabotaged its up-listing efforts which forced it to delay paying its dividend which led to a delay in its plans. It is prepared to litigate the matter if necessary.
  • Now read: Avoid CohBar: Red Flags And An Exorbitant Valuation


Original article

Latest comments

what is the Florida state securities division doing to investigate this companies CEO and Board of Director's. somebody(s) should be going to prison.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.